MDCO - The Medicines Company

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue167,835309,007659,690
Cost of Revenue71,347119,931233,330
Gross Profit96,488189,076426,360
Operating Expenses
Research Development139,262123,606139,512
Selling General and Administrative319,151337,943314,954
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-361,925-272,473-28,106
Income from Continuing Operations
Total Other Income/Expenses Net287,10235,30543,390
Earnings Before Interest and Taxes-74,823-214,57113,573
Interest Expense44,46337,09215,701
Income Before Tax-119,286-251,663-2,128
Income Tax Expense70-29,743-2,309
Minority Interest-518-464-474
Net Income From Continuing Ops-119,356-221,920181
Non-recurring Events
Discontinued Operations184-130,826-32,529
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-119,118-352,756-32,210
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-119,118-352,756-32,210